Toxicities and Outcomes for Patients with CNS Lymphoma (CNSL) Consolidated with High-Dose Therapy and Autologous Stem Cell Transplantation (HDT-ASCT) Using Thiotepa, Pharmacokinetically-Targeted (PK) Busulfan (Bu), Cyclophosphamide (TBC) Conditioning Michael Scordo, MD, Valkal Bhatt, PharmD, Meier Hsu, MS, Antonio M. Omuro, MD, Matthew J. Matasar, MD MS, Lisa DeAngelis, MD, Parastoo Dahi, MD, Craig H. Moskowitz, MD, Sergio A. Giralt, MD, Craig S. Sauter, MD Biology of Blood and Marrow Transplantation Volume 22, Issue 3, Pages S132-S133 (March 2016) DOI: 10.1016/j.bbmt.2015.11.465 Copyright © 2016 Terms and Conditions
Figure 1 Analysis of Grade 3-5 Non-Hematologic Toxicities Biology of Blood and Marrow Transplantation 2016 22, S132-S133DOI: (10.1016/j.bbmt.2015.11.465) Copyright © 2016 Terms and Conditions
Figure 2 Kaplan-Meier Curves for PFS and OS Biology of Blood and Marrow Transplantation 2016 22, S132-S133DOI: (10.1016/j.bbmt.2015.11.465) Copyright © 2016 Terms and Conditions